JPRN-UMIN000027648已完成未知
A poilot study of eribulin monotherapy in chemorefractory patients with BRAF V600E-mutant metastatic colorectal cancer - BRAVE PILOT study
Aichi Cancer Center Hospital0 个研究点目标入组 5 人开始时间: 2017年6月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Symptomatic brain, pia mater, or meningeal metastasis (2) Active infection (3) Interstitial pneumonia or pulmonary fibrosis (4) Serious complications (renal failure, liver failure, severe cardiac disease, uncontrolled diabetes, uncontrolled hypertension, ileus, cerebral infarction, cerebral hemorrhage) (5) Massive pleural, abdominal, or pericardial effusion with continuous drainage (6) Active gastrointestinal hemorrhage (7) Clinically significant mental disorder (8) Previous treatment with eribulin (9) Women who are pregnant or patients who are unwilling to avoid pregnancy (10) Patients who are inappropriate for the study in the opinion of the investigator
研究者
相似试验
已完成
2 期
Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who presented well-defined taxane resistanceBreast CancerJPRN-UMIN000006965Saitama Breast Cancer Clinical Study Group (SBCCSG)52
招募中
不适用
Exploratory clinical study of eribulin followed by taxane for metastatic breast cancer patientsMetastatic breast cancerJPRN-UMIN000027527Yamaguchi University Graduate School of Medicine30
已完成
2 期
A multicenter phase II study of eribulin monotherapy in patients with BRAF V600E mutant metastatic colorectal cancercolorectal cancerJPRN-UMIN000031221Aichi Cancer Center Hospital30
招募中
2 期
A phase II study of eribulin monotherapy for advanced extramammary Paget's diseaseJPRN-jRCT2011220022Yanagi Teruki18
招募中
2 期
Phase II study of the combination of Eribulin and Trastuzumab Evaluating Efficacy and Safety in Patients with advanced/recurrent HER2-positive breast cancer.Advanced/recurrent HER2-positive breast cancerJPRN-UMIN000011020Sairtama Breast Cancer Clinical Study Group (SBCCSG)na35